GlassScriptPhysician profile
Charles N Witten
NPI 1376518431
$6,049.15
in general payments reported to CMS, 2019-2025
30 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $408 · 2021: $626 · 2022: $1,840 · 2023: $615 · 2024: $731 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,880 · Travel and Lodging: $691 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,879.69 |
| Travel and Lodging | $691.45 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,057.67 | 2022-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $1,024.54 | 2022-2025 | General - Therapies, Lumenis Pulse 120h, Ams 700 |
| Myriad Genetic Laboratories, INC. | $630.49 | 2020-2025 | Prolaris, Myrisk |
| Endo Pharmaceuticals INC. | $559.91 | 2019-2024 | Xiaflex, Aveed |
| Teleflex LLC | $384.31 | 2021-2025 | Urolift, Barrigel |
| Urogen Pharma, INC. | $281.53 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $261.24 | 2019-2025 | Erleada |
| Coloplast Corp | $234.85 | 2019-2025 | Titan |
| Antares Pharma, INC. | $203.48 | 2019-2023 | Xyosted, Nocdurna, Tlando |
| Astellas Pharma US INC | $173.90 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $155.44 | 2024-2025 | Adstiladrin |
| Karl Storz Endoscopy-America | $110.47 | 2020-2022 | |
| Ambu INC. | $108.07 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.89 | 2020-2025 | |
| Abbvie INC. | $94.65 | 2022-2025 | Botox |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $93.01 | 2024-2025 | Xiaflex, Aveed |
| Neotract INC. | $88.54 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $72.20 | 2023-2024 | Orgovyx |
| Pfizer INC. | $62.04 | 2019-2023 | |
| Allergan, INC. | $57.33 | 2019-2021 | |
| Myovant Sciences INC. | $51.19 | 2021 | |
| Medtronic USA, INC. | $48.11 | 2019-2020 | |
| Olympus America INC. | $38.93 | 2020-2023 | Itind System |
| Laborie Medical Technologies Corp. | $37.54 | 2024 | Urgent PC Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter |
| Novartis Pharmaceuticals Corporation | $25.80 | 2025 | |
| Photocure INC | $24.93 | 2020 | |
| Halozyme INC | $22.99 | 2023 | |
| Accord Healthcare, INC. | $20.64 | 2023 | |
| 180 Medical, INC. | $18.71 | 2022 | |
| Dentsply Ih INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Witten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.